4 in 5 physicians surveyed believed nicotine directly causes cancer, yet combustion, not nicotine, is the main cause of smoking-related harm (Steinberg et al., 2021). The NHS has stated “Nicotine itself does not cause cancer” (Better Health, 2026).
Explore more at: ow.ly/PETF5107NoQ
Understanding smokeless products starts with scientific dialogue. We’ve published 275+ peer-reviewed papers and made many clinical-study protocols public so others can review or replicate them. Scrutiny is welcome.
Follow the evidence. Help build a smokeless future.
Find out more at: ow.ly/1SJJ5106PBF
A smokeless future depends on trust: in the quality of the products available, in the evidence behind them, and in consumers' ability to make informed choices.
Misperceptions about relative risk may discourage adult smokers from switching.
Learn more at: ow.ly/83fG5106mo5
Omni™ 2026 is here, with an updated look at Tobacco Harm Reduction (THR).
But what is THR?
Download Omni™ to find out: ow.ly/QHRi5105jya
For scientific, regulatory, policy, and investor audiences.
#Omni#SmokelessWorld
What happens when fans are given the opportunity to become part of the story?
Earlier this season, fans were invited to share their most original motorsport dreams.
At the Mexico City Grand Prix last week, VELO and the McLaren Racing Mastercard Formula 1 Team brought those ideas to life through the ‘Livery of Dreams’, with bespoke fan-inspired stickers featured across the McLaren car.
The activation put creativity and individuality at its heart, demonstrating the role partnerships can play in creating meaningful experiences that bring communities closer to the action.
When the possibilities narrow, imagination opens up.
That’s the view of Daniel Bonner, one of the creative minds behind Omni™.
On this week’s episode of The Smokeless Word, Daniel joins Kingsley to talk about what drew him to BAT’s transformation and why he’s so optimistic about what creativity can do.
He talks about the ambition behind A Better Tomorrow and why he sees narrower possibilities as a chance to open up the aperture of people’s imaginations.
Where have you seen creativity thrive under constraints?
🎧 Watch now: ow.ly/fU3n51041Kf
Science isn't static. Neither are we.
We listened to your feedback, challenged our own data and built on our first scientific compendium with the latest evidence.
The 2026 edition of Omni™ is the newest chapter in more than a decade of Tobacco Harm Reduction (THR) research, backed by a global scientific programme that includes:
👥 ~1,800 scientific colleagues across seven global locations
📝 288 scientific studies related to THR published in peer-reviewed journals
⚖️ 64 dedicated regulatory compliance specialists operating across four global hubs
Our aim? Robust, transparent science on Smokeless Products that regulators, scientists and public health experts can judge on its merits.
Because when evidence shapes public health policy, scientific rigour matters most.
Download the New Omni™ 2026 Edition today: ow.ly/bmpk5102RNL
Omni™ is intended for scientists, public health authorities, regulators, policymakers, and investors only, and is not intended for consumers.
We’re proud to have been recognised with the Tricentis Customer Innovation Award for AI Trailblazer at Transform 2026 Europe.
The award recognises our pioneering use of Agentic AI in Quality Engineering and our work to transform an initial proof of concept into a repeatable blueprint for wider enterprise adoption.
Using Tricentis Agentic Test Automation, the project converted natural-language and manual SAP testing steps into initial automation scripts, which were then reviewed and validated by experts.
The results? The proof of concept covered 12 business-critical scenarios and 423 manual process steps, achieving 100% initial script generation and indicating an approximately 70% acceleration in effort.
This is also the third consecutive year that BAT has been recognised by Tricentis for innovation, reinforcing our ambition to become a future-fit, data-driven organisation, harnessing AI and digital technologies to reduce complexity, improve efficiency and enable faster, higher-quality delivery.
#Innovation#AI#DigitalTransformation#Technology
Building a Smokeless World is a continuous journey.
Omni™ 2026 charts our progress as we turn years of research into real world policy impact.
From launching our first vapour products in 2013 to compiling more than 260 peer reviewed studies in 2024, that momentum continues with the release of Omni™ 2026.
This latest evolution moves beyond a scientific repository and gives policymakers actionable insights.
Review the evidence. Join the conversation.
Download Omni™ 2026: ow.ly/F1mS5100VgI
Omni™ is intended for scientists, public health authorities, regulators, policymakers, and investors only, and is not intended for consumers.
The Smokeless Word: Live from the Lab with Dr James Murphy is back!
And this time he’s joined by economist Professor Douglas Deng, whose research explores how the tobacco industry is evolving as next-generation products reshape the market.
His message for governments across Asia: “It is not very easy to get a one-size-fits-all solution for different countries.” But an evidence-based framework is a must.
Join James and Professor Deng as they explore what that means in practice, including the realities of tobacco-growing economies and the lessons from Japan’s heated tobacco market.
Tune in now: ow.ly/fe1A51001jg
Greece shows what happens when regulators allow for an objective assessment of the science-based evidence and independent verification of reduced‑risk messages. Since implementing this framework, adult smoking rates fell by 10% from 2020–2024, while heated product adoption doubled.
Jochen Hiller, cluster manager of our Greek market team, outlines the case study below.
Download the New Omni™ 2026 Edition*: asmokelessworld.com/gb/en?ut…#Omni#SmokelessWorld#NewOmni2026Edition
*Omni™ is intended for scientists, public health authorities, regulators, policymakers, and investors only, and is not intended for consumers.
Same goal. Different approaches. Different outcomes.
The UK & Netherlands share the same goal: to reduce smoking prevalence. But their approaches to nicotine regulation are associated with different outcomes.
Read the full case study in the New Omni™ 2026 Edition*: ow.ly/QY7o50ZXwpF
*Omni™ is intended for scientists, public health authorities, regulators, policymakers, and investors only, and is not intended for consumers.
70% of South Africans once believed in democracy. Now it's only 36%.
That shift matters well beyond the polling station. On the latest episode of The Smokeless Word, South Africa's former Statistician-General, Pali Lehohla, draws on HSRC survey data to explore what fading public trust could mean for elections and broader society.
His warning is stark: if turnout falls to 20-30%, "democracy collapses"
A sobering look at what's at stake when public confidence erodes.
Watch the full episode now: ow.ly/nVLi50ZXvVH
Could this cause harm? That's hazard.
How likely is harm under real conditions of exposure? That's risk.
Danni Tower, Group Head of Scientific Affairs at BAT, on a distinction explored in the New Omni™ 2026 Edition – out now. ow.ly/OGlg50ZWN8Z
Omni™ is intended for scientists, public health authorities, regulators, policymakers, and investors only, and is not intended for consumers
The latest episode of The Smokeless Word is officially live.
This week, Kingsley Wheaton sits down with South Africa's former Statistician-General, Pali Lehohla, to explore how data shapes a nation's story, strength and future.
From leading South Africa’s post-apartheid censuses to thinking about what comes next, Pali asks a hard question: what is his generation handing over to the next and what will they hand over in turn?
Tune in for a conversation about legacy, national progress and long-term vision.
Watch now: ow.ly/hFtM50ZWcH4
When governments enable evidence-led communication, public health benefits.
Our newly updated Omni™ 2026 edition features an updated look at Greece, where landmark legislation in 2020 created a framework for communicating government approved risk reduction information to adult consumers at the point of sale.
Since then, daily smoking rates have dropped while adoption of reduced risk profile alternatives has grown. Greece shows what happens when policy allows adult smokers who would otherwise continue to smoke to access scientific facts and information.
Review the evidence. Join the conversation.
Download the New Omni™ 2026 Edition today. Omni™ is intended for scientists, public health authorities, regulators, policymakers, and investors only, and is not intended for consumers.